A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP
| Author | Kazem Anvari | en |
| Author | Mehdi Seilanian-Toussi | en |
| Author | Hossein Hosseinzad-Ashkiki | en |
| Author | Soodabeh Shahidsales | en |
| Issued Date | 2015-04-30 | en |
| Abstract | Background: Chemotherapy- induced nausea and vomiting (CINV) occur frequently causing problems with an unacceptably high incidence that significantly affect patients' daily functioning and health-related quality of life. The present study was aimed to compare acute CINV for granisetron as 5-HT3 receptor antagonist and metoclopramide in the patients receiving chemotherapeutic regimens including cyclophosphamide and adriamycin. An attempt is made to examine whether it is possible to successfully replace granisetron with metoclopramide in control of acute CINV. | en |
| DOI | https://doi.org/ | en |
| Keyword | granisetron | en |
| Keyword | metoclopramide | en |
| Keyword | Chemotherapy induced nausea and vomiting | en |
| Keyword | Adriamycin | en |
| Keyword | cyclophosphamide | en |
| Publisher | Brieflands | en |
| Title | A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- IJCM-80594.pdf
- Size:
- 61.63 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF